An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment out...
An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment outcomes in lung adenocarcinoma
About this item
Full title
Author / Creator
Han, Tao , Liu, Yafeng , Wu, Jing , Bai, Ying , Zhou, Jiawei , Hu, Chunxiao , Zhang, Wenting , Guo, Jianqiang , Wang, Qingsen and Hu, Dong
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
In lung adenocarcinoma (LUAD), immune heterogeneity of hot and cold tumors has been recognized as one of the major factors affecting immunotherapy and other common treatments. However, there is still a lack of biomarkers that can effectively identify the immunophenotype of cold and hot tumors. First, the immune signatures were obtained based on lit...
Alternative Titles
Full title
An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment outcomes in lung adenocarcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d811b69578d94679919ed643bcb7354c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d811b69578d94679919ed643bcb7354c
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-023-32276-2
